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MAP kinsc kinw (MAPKK) WYL purified 3O.OOO~fald to homotjcncity from cx~rws of rubbit rkclctul murclc und shown to bc a monomeric 
protein of appilrsnl malccuhar mw 44 ~DJ, MAPKK rcliwtcd the 42 kDu isofomm of MAP kinur by phorphorylution oTThr-I83 end Tyr.185. 
und phojphoryl;ltcd iwlf dawly on tyrorinc. thrconinc imd rcrinc rcridua, cstublbhing that it is u ‘dual spsificity’ protein kinass. Pcptidcsqucnccs 
from MAPKK were homolo~our to other protcin scrinclthrcaninc kirwscs, crpciully to the rubrumily that includes yc;lst protein kinuses tht lie 
upstream of fcua MAP kinwc homdogucr in the phcromowdcpndcnr mutiny pr~hwnyr, 
Mitogcn.uctivntcd pmtcin (MAP) kinarc; Phcromonc: Protcin kinnrc; Siynul wuarduction: Ycrst 
1. INTRODUCTION 
Mitogcn-activated protein kinascs (MAP kinascs) 
rcprcscnt a family of protein scrinc/thrconinc kineses 
that arc activated rapidly in rcsponsc to many cxtraccl- 
luhr signals [121. Potential in vivo substrates for MAP 
kinasc include the transcription factor c#r and two 
protein kinascs termed S6 kinasc-11 4.51 (or insulin- 
stimulated protein kinuse- [a]) and MAP kinasc-acti- 
vatcd pratcin kinasc-2 [73, all of which arc activated by 
MAP kinasc in vitro. In mammalian skclctal mu&. S6 
kinasc-II activates the glycogcn-associated form of pro- 
tein phosphotasc-1 [6]. promoting dcphosphorylation 
(activation) of glycogcn synthasc and dcphosphorylo- 
tion (inactivation) of phosphorylasc kinasc, Thcsc 
events appear to underlie the stimulation of glycogcn 
synthesis and inhibition of glycogcnolysis by insulin [61. 
The physiological rolts of MAP kinasc-activated pro- 
tcin kinasc-2 arc not yet known. 
MAP kinasc is unique in requiring phosphorylation 
of a thrconinc and a tyrosinc residue to become active 
[S], and these regulatory phosphorylations occur at Thr- 
183 and Tyr-185 in the 42 kDa isoform of MAP kinasc 
[9], MAP kinasc activators which promote phosphoryl- 
sltion of these residues hnvc been identified in extracts 
of 3T3 cells [IO]. PC12 cells [l 11 and rabbit skeletal 
muscle [121, and were found to so-purify through scv- 
era1 steps of purification. Furthcrmorc, the ability to 
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phosphorylate Thr- 183 and Tyr- 185 was lost in parallel 
upon incubation with protein phosphatasc 2A (PP2A). 
a protein scrinc/thrconinc phosphlrtasc, but not by incu- 
bation with protein tyrosinc pt.xphntascs [ 11,121. The 
partially purified MAP kinasc .xtivator from skeletal 
muscle phosphorylatcd a kimrsc-inactive mutant of 
MAP kinasc on Thr-183 and Tyr-I85 in an identical 
manner to ‘wild-type’ MAP kinasc, indicating thst it is 
a protein kinasc (MAP kinnsc kinasc) [12], and not a 
protein whish stimulates uutophosphorylation of MAP 
kinasc [13,143. 
Rcccntly. Matsuda et al. [I 51 purified a MAP kinnsc 
activator to apparent homogcncity from mature XCWU- 
prto krevis oocytcs which promoted phosphorylation of 
recombinant Xcnoplts Irrcvis MAP kinasc on tyrosinc. 
thrconinc and scrinc rcsiducs. Hcrc WC purified MAP 
kinase kinasc (MAPKK) to homogcncity from rabbit 
skeletal muscle and cstablishcd that this enzyme is rcs- 
ponsiblc for phosphorylation of both Thr-183 and Tyr- 
185. Pcptidc scqucncing rcvcalcd that MAPKK is ho- 
mologous to other protein kinascs. especially to a sub- 
group that includes enzymes which lie on the phcro- 
monc-dcpcndcnt mating pathw.iys of yeasts. 
2. MATERIALS AND METHODS 
Rccombinnnt murinc?? kDa MAP kinnrc wnscnprcard 31 il ylura~ 
thionc&transfcrwz fusion protein in E. m/i. purified by nflinity 
chromatography on gluluthianc-Scphnror and clcavcd from gluta* 
thionc-S.trnnsfcraac with thrombin. as Icscrilxd previously [710 and 
~1% a pcncrour gili from Miss Sally Lccvcrr und Dr. Chris Marah;lll 
(Chester Batty Laboratories. Institute for Cancer Rcswch. Low 
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don). Rccombinunt human pratcin phosphatrrr ly wtts provided by 
Drs. Alrstiir S~rcct, Rario Alesi und Triciu Cohen in this Unit. 
Hcparin-Scphurorc. Supcrorc 12 and Mono Q wcw purchered from 
Phutmucb Ltd. (Milton Kcyncs, UK) und the sources of all other 
rcugcntti tire given in [ i2]. 
fnac~ivc raombinnnt MAP klnttsc wasdilutcd in 50 mM Tris*HC1. 
pH 7.5 (2O.C). 0.1 mM NuZGTA. 0.1% (v/v) ?.mrrcupfocthunol 
(rolulion A) canteining 0.04% (WV) Brij 35 10 yivc u conccntnttion of 
120 U/ml MAP kinasc after maximal activation by MADKK. A 5 ~1 
aliquot of inactive MAP kinasc was incubntcd for 3 min ill 3O’C with 
S ~1 of MADKK in solution A containing 0.04% (w/v) Erij 35 and 5 
~1 of IOU mM TrirmHCl, pH 7.5 (20X). 0.2 mM NeEGTA, 0.5 mM 
&ium onhovanudutc nnd 0.1% (v/v) 2.mcmptorthunol. nnd the 
activation of MAP kinlrr initiated with 5 pl of 40 mM milgttcsiurn 
rcctntc-O.8 mM unl&lled ATP. Control incubufionv wercurrricd out 
in parallel in which solution A, containing O&I% Brij 35, rcpluccd 
MAPKK or rccombinttnt MAP kinuse. After 20 min. the incubation 
was diluted S.fold in solution A containing I.0 mumI bovine strum 
albumin and 0.5 mM sodium arthovnnadntc. nnd LL 1011 slirtuot was 
added to 40~1 ofO,4 mJml myclin basic protein in solution Acontuin. 
ing the rpccifir peptidc inhibitor of ryclic AMP.dcpcndcnt protein 
kinasc a.tt PM (161, i2.S mM milSncsium ucctatc rend 0,125 mM 
[y”P]ATP (6 x IO’cpn-Jnmol) prcwnrmcd to 30.C. After incuhtion 
for IO min nl 30X incorporrtion of phorphatc into myclin basic 
protein was measured as dcrcribcd previously [It], One unit of MAP 
kinasc is that amount which cz~talyrcs the incorpontion of I ,O nmol 
of pho;photc into myclin basic profrin in I min. One unit of MAPKK 
is th;lt amount which produces 50% rcactivution of MAP kinnrc in I 
min. The activation of MAP kinttrc was Iincur with time up IO 30% 
reactivation and fractions containing MAPKK wcrc rhcrcforc Jilutcd 
appropriately before assay to ctuurc that initial NIC conditions wcrc 
met. 
All buffers cont;lincd 0. I8 iviv) 2~rncrcaptocfLn~l und 1 mM bcn. 
umidinc, EXtructr wcrc prcparcd from 1,EW 0 of skclctul muscle (Iwo 
rabbits) ond subjected to brtchwirr chromatography on QRE-SC. 
phadcx, praipirution with ummanium rulphutc and chrumutoytztphy 
on Q-Scphrrose. us dcscribcd previously [12], buf with the following 
modifications0 Firstly, the amount af QAE-Scphadcx resin WIS ins 
crcmxJ from 30 to 35 g (dry weight). Secondly, the cnxynrc wnx 
prccipitutcd with 60% (rather than 50%) ammonium rulprlutc (by the 
addilion of solid salt). Thirdly. the smmonium sulphale pcllc~ WYUL 
rcsuspcndcd in buffer containing 5 mM sodium pyroplw?!ue !F 
ensure compfctc inactivation of any remaining traces of protein phos. 
phatasc ?A. The peak of MAPKK from Q-Scphurorc [II] wus pooled, 
diluted iO*fold in 25 mM Trir-HCI. pH 7.4 (2O*C), I.0 mM Na. 
EDTA. 5% (WV) glycerol, 6.02% (w/v) Brij 35 (solution R), and chro. 
matogruphcd on hcparin-Scphnrorc UP dcscrihcd in the legend to Fig. 
IA. The fractions contuining MAPKK wcrc pooled, diluted S.S.fold 
in 25 mM Tris.HCI. pH 8.9 (2O’C), I.0 mM Ntt.EDTA, 5% (v/v) 
glycerol and 0.62% (w/v) Brij 35 (soluiion C) und opplicd to II 5 x 0.5 
cm column of MOIIO Q quilibrutcd in solution C. After washing with 
5 ml of equilibration buffer, the column wus dcvclopcd with ti 60 ml 
linear suit gradient to I .O M N&I, und 0.5 ml fractions wcrc collcctcd 
at a flow MC of I.0 ml/min. The active fractions. which clued LIY a 
single pcnk at 0.19 M NaCl (data not shown) wcrc pooled (2.5 ml), 
concentrated to 0.25 ml by ultmfiltrntion. diluted to 10 ml in solution 
B and chromntographcd on Mono S, IIS dcscribcd in the legend to Fig. 
18. The active fmctions were pooled, ronscntratcd IO 0.1 ml by ut- 
trafiltration and rubjcctcd to gcl~fillralion on Supcrosc 12, as dc. 
scribed in the legend to Fig. IC. The fractions containing MAPKK 
wcrc stored at -2O’C. 
MAPKK (0.5 ml tit 40ygIml,O.5 nmol) in solution Bcontaining 0.5 
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mM Nu.EGTA und 6.2 M NvCl was allowed IO autcrphosphorylntc 
for 60 min ut 3O’C by incubation with S mM mu~ncsium ai&tc, 0.2 
mM [y’:P)ATP (IO’ cptinmol). Poly Glflyr (50 pg) was added as 
Y carrier, and the solution Fxcipitutcd by rlrc addilion of 0.03 ml of 
100% (w/v) frichlorotlcclic acid. After ccntrifu@tion for 2 min at 
I3,coO x g the supcmatanl was dimrdcd and the psllcl mlshcd three 
times with trichloroacctir ucid IO remove ATP. and twice with w~lfcr 
to rcmovc lrichloronrctir ucid, The p&t was rcwpmdrd in 0.1 ml 
of 0.1 M ammonium bicnrbonutc. vorlcxcd und placed in II sonicuting 
water bttth for 10 min. Trypsin (0.6~8) was added ond after digstion 
for 2 h nt 37’C P further 0.6 #$ of lrypsin wtts added. After 16 h at 
37X. the solurion wus ccntrifugcd for 2 min PI 13,OOQ x g und the 
supcrnatunt chromutoyrnphcd on a Vydac Cl8 218TP54 rcvcrsc- 
phuss column quilibntcd in 0.1 ‘A IrilIuoraacctic acid. The column 
was developed with u linear gradient of ttatonitrilc containing 0.1% 
trifluoro;lcctis acid with un inrrcasc in ssctonitrilc conantmtion of 
0.33% per min. The flow rate ws 0.8 tnVmin and fractions of 0.4 ml 
wcrc collected, Pcprticr clutcd from the column wcrc squcnccd on an 
Applied Bioryrtems 47OA/l2OA wphnr squcncer. 
2.5. Irrrlttria~~ of rryprir plmsphuprprit~e~ /ran MAP hhttsc 
Recombinant MAP kinnss (I.4 ~0) was incubated for 30 min at 
30’C with purified MAPKK (0.03~& in u volumcof 30@ IL in section 
2.2.. but usins [y.‘?]ATP (lO*cpmInmol) instead of unlabcllcd ATP. 
Poly GltVTyr (56~0) wns added PI carrier and MAPKK prccipitatcd 
with 2 /tl of 100% (w/v) trkhlorottcctic acid. After csntrifu@tion for 
2 min nt 13,000 xl. the supcrnatrnt ws diccardcd and the precipitate 
washed with rriehloronoctic acid and wutcr, ns dcscribsd for MAPKK 
in section 2.4. The precipitate WDR rcsuspcndcd in 0,2 ml of 0.1 M 
ammonium bicarbonate nnd 10 ~0 tryprin nddcd. After 2 h nt 37.C 
u further IO $0 of trypsin WILL uddcd und digestion continued for II 
further 16 h. The digest WILL chromntographcd on u Cl8 column ns 
dcscribcd in section 3. 
2.6. 01lrrr trrrul,hw/ prmvhtrrr 
SDS-PAGE was carried out nccordina to Lxmmli [ltr], protein 
conccntrotions wcrc cstimntcd by the method of Bradford [IP] nnd 
phsophcrmino acid unulysir wnl~ pcrformcd us dcKribed in Gomcz 
and Cohen [t I ). 
3, RESULTS 
kirwse 
MAPKK clutcd US a sinale major pcuk of activity at 
cxh stage of its purification (Fig, I) and the isolation 
procedure is summarized in Table I. The overad cnrich- 
ment from muscle cntrscts WLLS over 30.000-fold and 
about 50 gg of purified cnzymc was isolated from 
1,gOO g muscle (2 rabbits) within G days, the overall 
recovery being 2%. At the final step, gel filtration on 
Supcrosc 12, activity coincided with a peak of protein 
which clutcd slightly cnrlicr than ovalbumin (43 kDa) 
and corresponded to the apparent molecular weight of 
45-50 kDa previously reported for the partially purified 
enzyme 1121. SDS-PAGE of the peak tubes from Sqxr- 
osc 12 revealed asingle 44 kDa protein (Fig. 2A), whose 
staining intensity corrclarcd with the peak of activity 
when individual fractions across the gel filtration col- 
umn were analyscd (data not shown). 
Two further pieces of evidence suggest hat the 44 
kDa protein is a protein kinasc. Firstly, the 44 kDa 
prolcin is inastia/atcd and 14C-labclled by inclrbation for 
60 min with pJluorosulphony1 [‘*C]bcnzoyl 5’-adcn- 
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Tnblc I 
Purification or MAP kinur kinurc rrom rubbit ~kclc’~l muscle 
August 1992 
slcp Volume (ml) Activity (U) Protein (mB) Spoclfc activity Puriticarion (-Told) Raovcry (%) 
(U/me) 
I, Extract 3,700 1211.000 8WtO I.0 100 
2. QAE-Scphudcx IO00 %8,&w) 2,520 3Y 25 69 
3. Ammonium sulphnrc 
prccipilnlion 66 71.300 2,970 24 17 56 
4, Q-Scpharose 21 51.500 30s 169 121 40 
5. Mcparin-Scpharosc I5 23,100 IS 1,540 1,100 18 
6. Mono Q 2.5 9.300 2.15 3,380 2.410 7,3 
7. Mono S 2.0 3.500 0.13 26,900 19.200 2.7 
8. Supcrorc 12 0.75 2.IOO 0.047 W,m 32,ooo I,6 
-- 
1&00 0 of mu& (two rabbits) wcrc used in this preparation. Activity was mcururcd as dcscrikd in scction 2. und prolcin was dctennincd by the 
proccdurc of Bmdford [19). 
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Fig. 1. PuriIication of MAP kinapc kinasc, (A) Hcparin-Sepharosc. 
MAPKK from step 4 (see Table 1) wus diluted in solution B and 
applied to the column (2.5 x I .6 cm) quilibratcd in the same buffer. 
After washing wi\h quilibration bull& unlil thc;Ibsorbrnccnt 280 nm 
was below 0.05, the column wu> &rclopcd with a 200 ml linear salt 
grndicnt to 0.5 M NaCI, The flow rate was 5 mVmin and fractions of 
I ml wcrc collcctcd. (B)Chronialognphy on Mono S, MAPKK from 
step 6 (see Tnblc I) wusconccnrrcltcd. iluted in solution 6 and applisd 
to Ihe column (5 x 0.5 cm) cquilibrirtcd in the same buffer. After 
washing with 5 ml of buffer, the column was dcvclopcd wiih an 80 ml 
lincpr gradicnr from 0 to 100 mM M&Cl,. The flow rdlc was 1,O mUmin 
and fractions of 0.5 ml wcrc cc&ctcd. (Ci Gel Rlrration on Supcroe 
12. MAPKK from slcp 7 (see Table 1) (0,I ml) was applied 10 lhc 
column (30 x 1.0 cm) quilibrdtcrl in solorion fl plus 0.5 mM Nit- 
EGTA and 0.2 M NaCI. The flow WC wtis 0.3 mVmin and fractions 
of 0.25 ml wcrc collccud. The m-row6 dcnorc thcvoid volume (Vo) and 
~hc mnrkcr proicins bovine xrum albumin (66 kDa) and ovalbumin 
(43 kDa), 7%~ closed circles show MAPKK ac!ivily, the open circle 
Ihc prolcin concsntntion or ubsorbrncc at 280 nm, the diagonal lines 
the salt gndicnts and the horixmtal bars the fmrtions pooled. 
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Fig. 2. SDS-PAGE ttnd twophorphoryhtion of puriftcd MAPKK. (A) 0,4 )rg of the psak fraction ofMAPKK activity from Supcrosc 12 (Fig, 
IC) WP; nhjc<teit ta ekctrophorcsis on II 15% palyaxyhmidc 8~1 according to kcmmli [RI] and stained with Coonutic blue (Lnc K). The 
molecultw weight mttrkcn (lanes Mf tire phospharylt~~ (97 IrDo). bovine serum albumin (66 kDtt), oualbumin (43 kDn) and carbonic unhydrasc 
(30 kDu). hliprtttion is from lop to bottom. (I3 amd C) Puriflcd MAPKK (?.Sirg in 85cll) WPI incubutcd for 60 min at 30% in solution B conruining 
0.5 mM Ns4Sfh, 02 M NsCI. I PM okudnic acid. 0.5 mM sodium ortl?ovttnndtttc. 5 mM mugncsium acctatc and 0.2 mM IyUP]ATP (IO’ 
rpm/nmol). An allqual of the incubtttion mixture W;LS subjcctcd to clcctropharesir au in (A) and tin autoradiograph of :hr pl ir rhown in (D). A 
further aliquot WIL prccipitutcd with trichloroctcctic ttrid und rubjcctcd to pltorphoumino u&d nnttlysir us dcrcribcd in sccrion 2. Phorpharylutcd 
eminct acids wcrc !ac;ttcd by wtoradiogr;lghy (Cf. The position% cf phosphotyrosinc tpY). phorphollwconinc (pT), phosphoscrinc (pS) and the 
point af lsnmplc upplicution (origin) arc mwkcd. 
osinc (data not sl~own), which modifies the ATP bind- 
ing sites of other protein kinases covnlrtztly [Xl]. Ssc- 
ondly. the 44 kDn band is JLP-labcllcd upon incubation 
at 30°C with 5 mM magnesium acetate and 0.2 mM 
[y”P]ATP (Fig. 2B), the lcvcl of ghosphorylation rcach- 
ing about 0.2 mol per mol prorcin after 60 min, This 
suggests that MAPKK, in common with most protein 
kinascs, is capable of phosphorylating itself at a low 
rate, Phcsphoumino acid analysis of the auto- 
phosphorylatcd MAPKK rcvctilcd the prcscncc of 
phosphotyrosinc. phosphothrconinc and phosphoscrinc 
(Fig. 2C). 
Homopncous preparntions of MAPKK phos- 
phorylatcd recombinant 42 kDa MAP kinasc in an 
identical manner to the partially purified enzyme 1121. 
Piiirsphollyiution carried out ns dcscribsd in section 2.5 
reached a plateau UC I .P P 0.4 mol phosphate per mol 
MAP kinasc [avcrugc oi two experiments), ut which 
186 
point the specific activity of the cnzymc rcochcd 1,250 
Uimg. Stoichiomctris phosphorylntion cf MAP kinnsc 
was attained by incubation with a SO-fold lower conscn- 
tration of MAPKK. establishing that the latter cnrymc 
does indeed act catalytically. Nearly all the “P radiouc- 
tivity was contained within the single tryptic pcptidc 
that contains Thr-t&3 and Tyr-18S (Fig. 3A), und this 
pcptidc contained phosphothrconinc and phosphoty- 
rosinc (Fig. 3B). 
Homogeneous MAPKK. like the partiully purified 
enzyme, was inactivated by PP2A and also by much 
higher lcvcls of protein phosphutasc 1 (PPl) activity 
(Fig. 4). The effects of PPI and PP2A were blocked by 
okadaic acid (Fig. 4), a potent inhibitor of thcsc en- 
zymes [21]. 
3.2. Structurul utdysis of MAP kituse kinase 
Tryptic pcptides wcrs is&tcd from MAPKK and 
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Fig. 3. Isolation and phosphoamino acid analysis of Ihe tryptis 
phosphopcpridc from MAP kinasc phosphorylatcd by MAPKK. (A) 
Rccombinnnt MAP kinasc (I ,4 ~8) was phosphorylatcd wlth purified 
MAPKK, prcsipitn!cd with trichlor-oacctic a id and digested with 
trypsin OS dcdcribcd in section 2. The digest waschromntographcd on 
a Vydas 218TP54 Cl8 column cquilibratcd in 0.1% (v/v) trifluoroilcc- 
tic acid. The column was dcvclopcd for 40 min with a lincnr ncctoni- 
trilc gradient from 0-60s rmd ‘!P radioactivity rccordcd with :III 
on-lint monitor. 37,000 cpm wcrc npplicd to the column and rodiox- 
tiviry was rccovcrcd qunntiiaGvcly. (B) Fractionscontaining the major 
tryptic phosphopcplidc in A wcrc pooled. dried and suhjcclcd to 
phosphoamino acid analysis ns describsd in s&on 2. The parilions 
of phosphotyrosinc (pY), phosphothrconinc (pT), phosphoscrinc (pS), 
inorganic phosphalc (Pi) and the point of mmplc nppliution (or&n] 
urc marked, Other “P-lubcllcd spots rcprcscnt phosphopcp~idca r - 
Ming from incornplctc hydrolysk 
August 1992 
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Fig, 4. fnnctivrrtion of MAPKK by protein Srflhr pkosphutam. 
MAPKK (48 U/ml) wus incubnlcd ~1 3O’C in 3 final volume of 4 ~1 
with rhc indicated conccntrnrions of PPI (0) or PEA (e) in 35 mM 
Trb+lCL pH 7.4 (2O’C). 0. I mM Na-EGTA. 0.3 mgIm1 bovine serum 
irlbumin. 0.02% (w/v) Drij 35 irnd 0.14b WV) 2~mcrcaptocth;lnol. The
phorphrtrsc reactions were tcrminnlcd after 30 min by !hc uddition 
of I pl of 40 PM okudric ;rcid. and cash incubation assayed for 
MADKK actiuity. Tlrc open andclosed ldnnglcs show control incuba- 
tions in which PPI und PP2A. rcspalivcly. wcrc lrcatrd with okuduic 
acid prior to incubrtion with MAPKK. One unit of proicin phosphr= 
wsc activity is thut amounl which c~~tulyr*i the rcleslrr of I /rmol of 
phosphalc from glywgcn phorphoryhsc in 1 min 1291. Similar rcsul~r 
wrrc obtuincd in scvcrul dilWcnt cxpcrimcntr. 
squcnccd. One pcptidc (pcptidc I in Table II) som- 
mcnccd with P prolinc residue. Since trypsin does not 
normally clcavc Arg-Pro or ‘Lys-Pro pcptidc bonds. 
this suggcstcd that this pcptidc might correspond to the 
N-terminus of the protein, an idea confirmed by so- 
qucncc analysis of the intact protein (data not shown). 
The scqucnccs of two further pcptidcs (pcptidcs 2 nnd 
3 in Table II) wcrc homolagous to those found in other 
protein scrinclthrconinc kinascs. Pcptidc 2 corrc- 
spondcd to the end of Domain I and the beginning of 
Domain II. while pcptidc 3 corresponded to Domain 
VIb [22]. Table II also shows the homologous cqucnccs 
of other protein kinnscs that these pcptidcs rcscmblc 
lnost closely. and thcsc similarities arc considered fur- 
thcr in section 4. 
4. DISCUSSION 
In this ptlpcr WC have purified MAPKK to homogc- 
ncity from rabbit skclctal muscle and cstablishd that 
187 
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it is a monomeric protein with an apparent molecular 
weight of 44 kDa. Its slightly slower migrulion than 
ovolbumin on SDS-PAGE is idcntioal to a MAP kinase 
activator isolated recently from mature Xe~~upus / crc\$s 
oo<ytcs [IS]. Howcvcr, whereas only 900.fold purifica- 
tion was npparcntly rcquircd to obtain homogcncous 
MAP kinesc activator from oocytcs, over 30,00O=fold 
purifiwtion was needed to purify the skeletal muscle 
cnzyms (Table I), This diffcrcncc could cithcr bc cx- 
plainsct by a 30-fold higher oonocntration of MAPKK 
in oocytcs and/or by n low lcvcl of activation of 
MAPKK in skclctal muscle, despite prior stimulation 
with insulin. The latter explanation would imply that 
the phosphorylatcd and dephosphorylatcd forms of 
MAPKK were separated uring the purification. 
The finding that homogeneous preparations of 
MAPKK phosphorylntc Thr-183 and Tyr-185 on MAP 
kinasc (Fig. 3A.B) qnd autophosphorylatc on Tyr. Thr 
and Scr residues (Fig. 2C) establishes that MAPKK is 
indsed a ‘dual specificity’ protein kinasc that is capable 
of phosphorylnting all three hydroxyamino acids. 
WC have reported that partially purifisd MAPKK is 
inactivated by pm-incubation with PP2A. but not by 
protein tyrosinc phosphatases, indioating that MAPKK 
is likely CO be activated by Scr/rhr phosphorylation [ 111, 
and this rssult was confirmed with the Xcr~oprls oocytc 
enzyme [15]. Homogcncous MAPKK was not only in- 
activated by PP2A, but ulso by PPI, albeit at a much 
higher concentration (Fia. 4). This provides further cvi- 
dcncc that MAPKK is regulated by Scrmhr and not Tyr 
phosphorylation, because PPl is dcvnid of activity to- 
wards any phosphotyrosinc residue so far tested [23]. 
The sequencing of tryptic pcptidcs from MAPKK 
established its homology to other protein kinascs, the 
scqucnoc orresponding to Domain VIb being characm 
tcristic of classical protein SerII’hr kinascs, rather than 
Tnblc II 
Homology between MAPKK und protein kinascs of rhc byrl family 
PCP Protein Pcptidc rqucncc Domain 
tide kinasc 
I MAPKK PKKK FTPIQLNPAPD N-terminus 
byrl MPKRRRNPKCLVLNPNAS N.tcrminur 
2 MAPKK VSHKPSCLVMAR I/II 
PBS2 VLHKPTNVIMAT 1111 
STE7 ALHVPDSKIVAK I/II 
byrl VKHR- -NIFMAt? I/II, 
3 MAl’KK DVKPSNILV?ISf? V!b 
STEI DIKPSNVLINSK Ylb 
byrl DLKPSNVWNSR YIb 
Squcnccs wcrc obtained by starching the OWL composite datnbuac 
V.16.1 and from [215]. Pcptidcs 1, 2 and 3 wcrc clutcd from the Cl8 
column at 23,5,17 and 19.5% occtonitritc, rcspcctivcly, Protein kinuac 
domains urc us defined in [22]. 
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protein Tyr kinnscs [22], Thus MAPKK is a further 
member of the new class of protein kinasw which rc- 
scmblc lassical protein Scrflhr kinascs most c oscly in. 
structure, but arc capable of phosphorylating Tyr as, 
well as Scrnhr residues [24]. 
Tryptic pcptidc 3 was very similar to sequcnoes found’ 
in one particular subclass of protein Scrmhr kinascs. 
that comprises four yeast enzymes termed STE7, byrl, 
PBS2 and wisl [25,26], The homology with STE7 of S.. 
ccrevisioc (and its homologuc byrl in S. pa&r [27]) is 
of considcrablc inters% bcoausc this protein kinase is 
known from genetic studios to bc involved in thcactiva- 
tion of the protein kinascs FUS3 and KSSL, which arc 
required for induction of mating-specific genes [28]. 
FUS3 and KSSl show about 55% amino acid sequence 
identity to one another. as well as to mammalian MAP 
kinascs. and contain the Thr-Glu-Tyr scquenoc 
phosphorylatcd by MAPKK. Furthermore, it has been 
shown that FUS3 bccomcs phosphoylatcd on these 
two residues in response to stimulation by pheromones 
which coordinate the physiological changstr that allow 
yeast oells to mate [28]. Tryptic pcptide 2 is located in 
a region that is not as wsll conserved as Domain VIb 
between dilTcrent protein kinascs, Nclitrthclsss, the 
most similar scqucncc to pcptidc 2 in the GWLcompos- 
itc data bosr: was the homologous pcptidc from PBS2, 
Furthcrmorc, the N-terminal pcptidc 1: of MAPKK 
showed significant homology to the N-tcrininus of byr 1 
(Table II). These observations suggest hat at least two 
components of the protein kinasc oascadc which is trip 
gcrcd by insulin and growth factors, and which leads to 
the activation of MAP kinasc in mammalian cells, arc 
analogous to protein kinases in the casoadc which is 
triggered by mating phcromoncs in ycnst. 
The finding that MAPKK from rabbit skclctul mus- 
cle has o free N-terminus may facilitate comparison 
with other forms of this cnzymc that arc currently being 
isolated from different cells and tiasucs, and hcncc pro- 
vide a rapid answer to the question of whether tissuc- 
specific isoforms exist. 
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